NCT02617459View on ClinicalTrials.gov

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

366

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions

Primary Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

Levobetaxolol eye drops

one drop per time; twice daily

DRUG

Betaxolol eye drops

one drop per time; twice daily

Trial Locations (1)

510060

Zhongshan ophthalmic center, Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY

NCT02617459 - Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter